GPT Healthcare Gears Up for Q3 Reveal on 2nd February; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

GPT Healthcare’s Q3 results FY26 are scheduled to be announced on 2nd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

GPT Healthcare Q3 Results 2026 Preview

• GPT Healthcare’s revenue is expected to be in the range of ₹102.21 crore, a 3.27% YoY decrease. 
• Profit After Tax, or PAT, is projected to fall by 17.37% YoY. 
• Net profit is ₹12.25 crore, fall  17.37% YoY 
• EBITDA to rise 10.91%

GPT Healthcare Share Performance 

• Over the past six months, GPT Healthcare’s share price has fallen by 28.23% to ₹128.73.
• Moreover, over the past year, the stock has decreased by 22.53%.
• Despite this weak short-term performance, GPT Healthcare’s stock has delivered a financially sound 25.07% return over the past 5 years.
• As of 1st February 2026, the stock traded at ₹128.73 per share.

Key Factors to Watch for GPT Healthcare Q3 Results FY26 

• Revenue Growth & Case Mix: Look for top‑line growth, driven by patient volumes, occupancy trends and higher Average Revenue Per Occupied Bed (ARPOB). Strong operational performance often underpins revenue gains.
  
• Profitability & Margins: Watch EBITDA and PAT margins — analysts recently highlighted margin compression and rising costs as key near‑term issues to monitor.
  
• Occupancy & Bed Utilisation: Bed occupancy rates and utilisation across hospitals are critical in a hospital operator’s results, influencing both revenue and cost absorption.
  
• Cost Structure & Expenses: Trends in employee costs, finance costs, and operating expenses can significantly impact profitability, especially with new facilities (e.g., Raipur) still ramping up.
  
• Expansion Progress & New Facilities: Commentary on new hospital openings, bed capacity ramp‑up, and asset‑light expansion models (e.g., Jamshedpur pipeline) will shape forward growth expectations.
  

Final Thoughts

GPT Healthcare will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 3.27% YoY revenue growth, a 17.37% fall in PAT, and a 10.91% fall in EBITDA. GPT Healthcare focuses on providing diagnostic, pathology, and preventive healthcare services through a network of labs and health centres.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here